Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Asthma | 10 | 2019 | 4383 | 1.47 | Why? |
| Anti-Asthmatic Agents | 4 | 2018 | 427 | 1.38 | Why? |
| Hypersensitivity | 8 | 2020 | 1137 | 1.30 | Why? |
| Desensitization, Immunologic | 3 | 2020 | 574 | 1.12 | Why? |
| Insect Bites and Stings | 3 | 2018 | 63 | 0.88 | Why? |
| Wasp Venoms | 1 | 2018 | 6 | 0.76 | Why? |
| Bronchial Hyperreactivity | 1 | 2017 | 38 | 0.72 | Why? |
| Bee Venoms | 1 | 2018 | 43 | 0.71 | Why? |
| Penicillins | 1 | 2019 | 132 | 0.70 | Why? |
| Allergy and Immunology | 4 | 2020 | 240 | 0.62 | Why? |
| Biological Therapy | 2 | 2018 | 456 | 0.60 | Why? |
| Nasal Polyps | 1 | 2018 | 221 | 0.57 | Why? |
| Omalizumab | 1 | 2017 | 158 | 0.56 | Why? |
| Respiratory Sounds | 1 | 2017 | 294 | 0.55 | Why? |
| Urticaria | 2 | 2018 | 472 | 0.55 | Why? |
| Calcium Channel Blockers | 1 | 2017 | 367 | 0.54 | Why? |
| Anaphylaxis | 5 | 2021 | 940 | 0.52 | Why? |
| Drug Hypersensitivity | 2 | 2019 | 401 | 0.51 | Why? |
| Drug Costs | 1 | 2017 | 313 | 0.50 | Why? |
| Allergens | 2 | 2018 | 728 | 0.48 | Why? |
| Bronchodilator Agents | 1 | 2017 | 444 | 0.47 | Why? |
| Precision Medicine | 2 | 2018 | 1477 | 0.40 | Why? |
| Dermatitis, Atopic | 1 | 2018 | 714 | 0.39 | Why? |
| Adrenergic beta-2 Receptor Agonists | 1 | 2011 | 142 | 0.39 | Why? |
| Rhinitis, Allergic | 1 | 2017 | 704 | 0.39 | Why? |
| Rhinitis, Allergic, Seasonal | 2 | 2017 | 121 | 0.31 | Why? |
| Biological Products | 1 | 2018 | 2331 | 0.25 | Why? |
| Olfaction Disorders | 1 | 2020 | 3704 | 0.24 | Why? |
| Antibodies, Monoclonal | 2 | 2018 | 8041 | 0.23 | Why? |
| Phenotype | 3 | 2018 | 4037 | 0.21 | Why? |
| Heart Diseases | 1 | 2017 | 3503 | 0.21 | Why? |
| Observation | 1 | 2019 | 80 | 0.20 | Why? |
| Hymenoptera | 1 | 2018 | 13 | 0.19 | Why? |
| Skin Tests | 1 | 2019 | 229 | 0.18 | Why? |
| Cell Membrane Permeability | 1 | 2017 | 84 | 0.17 | Why? |
| Muscle Contraction | 1 | 2017 | 60 | 0.17 | Why? |
| Venoms | 1 | 2017 | 24 | 0.17 | Why? |
| Interleukin-33 | 1 | 2018 | 120 | 0.17 | Why? |
| Nasal Obstruction | 1 | 2017 | 131 | 0.16 | Why? |
| Insecta | 1 | 2017 | 122 | 0.16 | Why? |
| Sublingual Immunotherapy | 1 | 2017 | 88 | 0.16 | Why? |
| Albuterol | 2 | 2020 | 105 | 0.16 | Why? |
| Immunotherapy | 2 | 2018 | 2421 | 0.13 | Why? |
| Cost-Benefit Analysis | 3 | 2020 | 2259 | 0.13 | Why? |
| Patient Participation | 1 | 2020 | 829 | 0.12 | Why? |
| Salmeterol Xinafoate | 1 | 2011 | 28 | 0.12 | Why? |
| Receptors, Adrenergic, beta-2 | 1 | 2011 | 32 | 0.11 | Why? |
| Formoterol Fumarate | 1 | 2011 | 61 | 0.11 | Why? |
| Health Care Costs | 1 | 2019 | 1007 | 0.11 | Why? |
| Ethanolamines | 1 | 2011 | 71 | 0.11 | Why? |
| Humans | 32 | 2021 | 930598 | 0.11 | Why? |
| Receptors, Glucocorticoid | 1 | 2011 | 118 | 0.10 | Why? |
| Respiratory Function Tests | 1 | 2017 | 1755 | 0.10 | Why? |
| Health Literacy | 1 | 2020 | 1078 | 0.10 | Why? |
| Nitric Oxide | 1 | 2017 | 769 | 0.10 | Why? |
| Delayed-Action Preparations | 1 | 2011 | 291 | 0.10 | Why? |
| Adrenal Cortex Hormones | 3 | 2017 | 6537 | 0.09 | Why? |
| Treatment Outcome | 4 | 2017 | 51732 | 0.09 | Why? |
| Ambulatory Care Facilities | 1 | 2020 | 2063 | 0.09 | Why? |
| Cross-Over Studies | 1 | 2011 | 867 | 0.09 | Why? |
| Skin | 1 | 2019 | 2096 | 0.08 | Why? |
| Periodicals as Topic | 1 | 2019 | 1492 | 0.07 | Why? |
| Immunoglobulins, Intravenous | 1 | 2017 | 2705 | 0.07 | Why? |
| Diagnosis, Differential | 2 | 2017 | 7220 | 0.07 | Why? |
| Meta-Analysis as Topic | 1 | 2011 | 1289 | 0.07 | Why? |
| Multicenter Studies as Topic | 1 | 2011 | 2437 | 0.07 | Why? |
| Burnout, Professional | 1 | 2020 | 2489 | 0.07 | Why? |
| Drug Interactions | 1 | 2011 | 1653 | 0.07 | Why? |
| Practice Guidelines as Topic | 2 | 2017 | 15421 | 0.06 | Why? |
| RNA, Messenger | 3 | 2021 | 5131 | 0.06 | Why? |
| Drug Therapy, Combination | 2 | 2017 | 7268 | 0.06 | Why? |
| Vaccines | 1 | 2021 | 3692 | 0.06 | Why? |
| Inflammation | 2 | 2017 | 13255 | 0.06 | Why? |
| Terbutaline | 1 | 2020 | 35 | 0.05 | Why? |
| Physicians | 1 | 2020 | 4214 | 0.05 | Why? |
| Guilt | 1 | 2020 | 74 | 0.05 | Why? |
| Self Administration | 1 | 2020 | 125 | 0.05 | Why? |
| Double-Blind Method | 1 | 2011 | 5988 | 0.05 | Why? |
| Animals | 3 | 2018 | 78931 | 0.05 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 3832 | 0.05 | Why? |
| Genotype | 1 | 2011 | 4697 | 0.05 | Why? |
| Medical Overuse | 1 | 2021 | 146 | 0.05 | Why? |
| Markov Chains | 1 | 2020 | 502 | 0.04 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2011 | 3607 | 0.04 | Why? |
| Leukotriene Antagonists | 1 | 2017 | 37 | 0.04 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.04 | Why? |
| Professionalism | 1 | 2020 | 171 | 0.04 | Why? |
| Spirituality | 1 | 2020 | 228 | 0.04 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.04 | Why? |
| Monte Carlo Method | 1 | 2019 | 577 | 0.04 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2017 | 10649 | 0.04 | Why? |
| Delivery of Health Care | 2 | 2020 | 15909 | 0.04 | Why? |
| Efficiency | 1 | 2020 | 420 | 0.04 | Why? |
| Histamine Antagonists | 1 | 2017 | 203 | 0.04 | Why? |
| Health Status | 2 | 2020 | 3259 | 0.04 | Why? |
| Pandemics | 9 | 2021 | 389249 | 0.04 | Why? |
| Immunologic Deficiency Syndromes | 1 | 2020 | 368 | 0.04 | Why? |
| Cytokines | 1 | 2018 | 15010 | 0.04 | Why? |
| African Americans | 1 | 2011 | 3363 | 0.04 | Why? |
| Child | 3 | 2020 | 70012 | 0.04 | Why? |
| Grief | 1 | 2020 | 320 | 0.04 | Why? |
| Infant | 1 | 2017 | 30274 | 0.03 | Why? |
| Mindfulness | 1 | 2020 | 437 | 0.03 | Why? |
| Prospective Studies | 1 | 2019 | 43301 | 0.03 | Why? |
| London | 1 | 2020 | 2166 | 0.03 | Why? |
| Mental Health | 1 | 2020 | 15770 | 0.03 | Why? |
| Administration, Intranasal | 1 | 2017 | 1132 | 0.03 | Why? |
| Patient Preference | 1 | 2020 | 750 | 0.03 | Why? |
| United States | 2 | 2017 | 46150 | 0.03 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.03 | Why? |
| Decision Support Techniques | 1 | 2020 | 903 | 0.03 | Why? |
| Quality Assurance, Health Care | 1 | 2017 | 596 | 0.03 | Why? |
| Bias | 1 | 2017 | 1109 | 0.03 | Why? |
| Patient-Centered Care | 1 | 2020 | 860 | 0.03 | Why? |
| Syndrome | 1 | 2017 | 1310 | 0.03 | Why? |
| Social Behavior | 1 | 2020 | 882 | 0.03 | Why? |
| Administration, Oral | 1 | 2017 | 2340 | 0.03 | Why? |
| Physician-Patient Relations | 1 | 2020 | 1266 | 0.02 | Why? |
| Social Media | 2 | 2020 | 5798 | 0.02 | Why? |
| Lung Diseases, Obstructive | 1 | 2008 | 46 | 0.02 | Why? |
| Lung | 1 | 2017 | 31049 | 0.02 | Why? |
| Respiratory Hypersensitivity | 1 | 2008 | 103 | 0.02 | Why? |
| Suicide | 1 | 2020 | 1500 | 0.02 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.02 | Why? |
| Health Promotion | 1 | 2020 | 2020 | 0.02 | Why? |
| Consensus | 1 | 2021 | 6345 | 0.02 | Why? |
| Hypersensitivity, Immediate | 1 | 2008 | 134 | 0.02 | Why? |
| Diagnostic Techniques and Procedures | 1 | 2008 | 265 | 0.02 | Why? |
| Substance-Related Disorders | 1 | 2020 | 2038 | 0.02 | Why? |
| Risk | 1 | 2017 | 5288 | 0.02 | Why? |
| Health Care Rationing | 1 | 2020 | 2558 | 0.02 | Why? |
| Immunologic Tests | 1 | 2008 | 445 | 0.02 | Why? |
| Dermatitis, Allergic Contact | 1 | 2008 | 185 | 0.02 | Why? |
| Computer Simulation | 1 | 2019 | 4982 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2017 | 3228 | 0.02 | Why? |
| Stress Disorders, Post-Traumatic | 1 | 2020 | 2963 | 0.02 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.02 | Why? |
| Food Hypersensitivity | 1 | 2008 | 397 | 0.01 | Why? |
| Communication | 1 | 2020 | 5206 | 0.01 | Why? |
| Adaptation, Psychological | 1 | 2020 | 4996 | 0.01 | Why? |
| United Kingdom | 1 | 2020 | 18046 | 0.01 | Why? |
| Telemedicine | 2 | 2020 | 25032 | 0.01 | Why? |
| Adolescent | 2 | 2020 | 86841 | 0.01 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.01 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.01 | Why? |
| Depression | 1 | 2020 | 14116 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Immunity, Cellular | 1 | 2008 | 3614 | 0.01 | Why? |
| Anxiety | 1 | 2020 | 17311 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2017 | 48226 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2008 | 22971 | 0.01 | Why? |
| Adult | 1 | 2020 | 244371 | 0.00 | Why? |
| Middle Aged | 1 | 2020 | 270681 | 0.00 | Why? |
Oppenheimer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(155)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(93)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_